Company Information

    Ambrx was founded on January 2003. The company is based in La Jolla, CA, USA . The number of employees in Ambrx is less than 250. Ambrx develops protein therapeutics that preserve potency, reduce dosing frequency, and improve homogeneity of the drug substance.
      If you are the founder or part of the founding team, please tell the world your story


          Funding & investors

          Ambrx has received 7 rounds of venture funding. The total funding amount is around $347.9M. Last venture funding round was $200M, announced on November, 2020.

            Similar Companies [beta]

              Venture Categories

                Active Venture Investors




                  Venture Competitors

                    News

                        Ambrx - Blog

                          • Scientist II/Senior Scientist – Upstream Process Development Cell Culture

                          • Job: 2022FR-04 Ambrx is a biopharmaceutical company enabling a new field of protein medicinal chemistry, using a fundamentally new technology that directs incorporation of amino acids beyond nature’s conserved set into biosynthetic proteins to produce high value biologics products.  Ambrx is seeking a highly motivated Scientist to be a key member of a fast-paced and […]The post Scientist II/Senior Scientist – Upstream Process Development Cell Culture first appeared on Ambrx.
                          • Senior Manager, SEC Reporting and Technical Accounting

                          • Job Code: 2022BR-07 Ambrx (NYSE: AMAM) is a clinical-stage biologics company focused on discovering and developing a novel class of specific and selective engineered precision biologics, using our proprietary platform technology that allows site-specific incorporation of synthetic amino acids (SAAs) into proteins within living cells. Our product candidates are designed to overcome the inherent limitations […]The post Senior Manager, SEC Reporting and Technical Accounting first appeared on Ambrx.
                          • Scientist, Downstream Process Development

                          • Job: 2022FR-02 Ambrx is a biopharmaceutical company enabling a new field of protein medicinal chemistry, using a fundamentally new technology that directs incorporation of amino acids beyond nature’s conserved set into biosynthetic proteins to produce high value biologics products. We are seeking an independent, experienced, and self-motivated Scientist to be a key member of the […]The post Scientist, Downstream Process Development first appeared on Ambrx.
                          • Assistant Controller

                          • Job: 11-22BA Ambrx (NYSE: AMAM) is a clinical-stage biologics company focused on discovering and developing a novel class of specific and selective engineered precision biologics, using our proprietary platform technology that allows site-specific incorporation of synthetic amino acids (SAAs) into proteins within living cells. Our product candidates are designed to overcome the inherent limitations of […]The post Assistant Controller first appeared on Ambrx.
                          • Drug Safety Associate

                          • Job: 86-21BA About Ambrx: Ambrx Inc., is a clinical-stage biopharmaceutical company focused on developing Precision Biologics using an expanded genetic code. Ambrx technology uses an expanded genetic code to incorporate synthetic amino acids into protein, all completed within a living cell. These synthetic amino acids enable the creation of Precision Biologics, an exciting new class […]The post Drug Safety Associate first appeared on Ambrx.
                          • Assistant Manager, Clinical Supply Logistics

                          • Job: 08-22BA About Ambrx: Ambrx, Inc. is a clinical-stage and growing biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Unlike conventional conjugation technologies that creates a mixture of suboptimal molecules, Ambrx technology incorporates non-natural amino acids beyond the common twenty into the protein biosynthesis, enabling site specific conjugation of small molecules, such as, […]The post Assistant Manager, Clinical Supply Logistics first appeared on Ambrx.

                          Share:     facebook    twitter    linkedin    reddit    email

                            Ventures Media is one of the largest startup and venture capital communities for startup and venture capital funding information and analysis.

                            Leave a Reply

                            Your email address will not be published. Required fields are marked *